Kisho

Sobi, Inc. — Rare Disease Pipeline | Kisho | Kisho

Sobi, Inc.

Other

Orphan Designations

FDA Approvals

Rare Diseases

News Articles

Disease	Drug(s)	Designation	Approved
Grant syndrome	Emapalumab	Orphan Designation	-
autoimmune thrombocytopenic purpura	avatrombopag maleate	Orphan Designation	-
cellular phase chronic idiopathic myelofibrosis	Vonjo	Orphan Designation	-
chemotherapy-induced alopecia	avatrombopag maleate	Orphan Designation	-
chemotherapy-induced hypertension	avatrombopag maleate	Orphan Designation	-
chemotherapy-induced toxicity	avatrombopag maleate	Orphan Designation	-
dermatomyositis	Vonjo	Orphan Designation	-
essential thrombocythemia	Vonjo	Orphan Designation	-
graft versus host disease	Emapalumab	Orphan Designation	-
platelet-type bleeding disorder 20	avatrombopag maleate	Orphan Designation	-
post-thrombotic syndrome	Vonjo	Orphan Designation	-
post-traumatic epilepsy	Vonjo	Orphan Designation	-
post-traumatic stress disorder	Vonjo	Orphan Designation	-
post-vaccinal encephalitis	Vonjo	Orphan Designation	-
primary biliary cholangitis	Vonjo	Orphan Designation	-
primary cutaneous lymphoma	Vonjo	Orphan Designation	-
primary myelofibrosis	Vonjo	Orphan Designation	-
radioulnar synostosis with amegakaryocytic thrombocytopenia 1	avatrombopag maleate	Orphan Designation	-
radioulnar synostosis with amegakaryocytic thrombocytopenia 2	avatrombopag maleate	Orphan Designation	-
thrombocytopenia 4	avatrombopag maleate	Orphan Designation	-
thrombocytopenia 5	avatrombopag maleate	Orphan Designation	-